Clearbridge Investments, LLC Incyte Corp Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $389,427 - $476,477	-5,671 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $6,537 - $8,643	86 Added 1.54%	5,671 $461,000
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $7,185 - $8,695	-89 Reduced 1.57%	5,585 $486,000
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $32,241 - $41,572	-379 Reduced 6.26%	5,674 $509,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $5.52 Million - $8.11 Million	-74,464 Reduced 92.48%	6,053 $629,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $2.44 Million - $3.32 Million	-38,570 Reduced 32.39%	80,517 $5.9 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $57,774 - $75,714	791 Added 0.67%	119,087 $10.2 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $122,119 - $145,094	1,677 Added 1.44%	118,296 $8.78 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $568,750 - $686,183	7,736 Added 7.1%	116,619 $0
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $232,375 - $322,349	3,656 Added 3.47%	108,883 $9.37 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $10,530 - $12,589	180 Added 0.17%	105,227 $6.69 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $28,899 - $34,739	468 Added 0.45%	105,047 $7.26 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $418,769 - $577,950	6,882 Added 7.04%	104,579 $7.01 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $1.08 Million - $1.32 Million	13,036 Added 15.4%	97,697 $8.14 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $2.55 Million - $3.18 Million	27,249 Added 47.46%	84,661 $8.02 Million
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $1.02 Million - $1.3 Million	-9,388 Reduced 14.05%	57,412 $6.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,800	66,800 $8.41 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account